Exceptional Long-Term Results of Efemoral Medical’s Vascular Scaffold System in Femoropopliteal Disease
Efemoral Medical announced the long-term results of its EFEMORAL I clinical trial, showcasing the durability and effectiveness of the Efemoral Vascular Scaffold System (EVSS) in treating femoropopliteal disease. Key findings from the trial included a remarkable 97% primary patency rate and low rates of reintervention over three years. The trial emphasizes the innovative design of the EVSS, which aims to provide an effective treatment for patients suffering from Peripheral Arterial Disease (PAD) without the need for a permanent implant.
Novel bioresorbable scaffold demonstrates primary patency rate of 97% at 3 years, indicative of long-term efficacy Achieved 1% post-procedural residual stenosis rate — lowest rate ever reported in a clinical trial of femoropopliteal intervention LOS ALTOS, Calif., April 21, 2026…